| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C15H21N3O2
|
|---|
| Exact mass |
275.1634
|
|---|
| Mol weight |
275.35
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
|
|---|
| Brite |
Phytochemical compounds [BR:br08003]
Alkaloids
Alkaloids derived from tryptophan and anthranilic acid
Pyrroloindole alkaloids
C06535 Physostigmine
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EB Parasympathomimetics
S01EB05 Physostigmine
D00196 Physostigmine (USP)
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB19 Physostigmine
D00196 Physostigmine (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
DG01132 Physostigmine
D00196 Physostigmine
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG01132 Physostigmine
D00196 Physostigmine
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D00196 Physostigmine (USP)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C1z C 26.1396 -14.1174
2 C8y C 24.8762 -14.5385
3 C1y C 26.9819 -15.2404
4 C1x C 26.9819 -12.9242
5 C1a C 25.2973 -12.9943
6 C8y C 24.8762 -15.9423
7 C8x C 23.6128 -13.8366
8 N1y N 26.1396 -16.3635
9 N1y N 28.3155 -14.8193
10 C1x C 28.3155 -13.3453
11 C8x C 23.6128 -16.6442
12 C8y C 22.4195 -14.5385
13 C1a C 26.5608 -17.6971
14 C8x C 22.4195 -15.9423
15 O7a O 21.2264 -13.8366
16 C7a C 20.0332 -14.5385
17 N1b N 18.8399 -13.8366
18 O6a O 20.0332 -15.9423
19 C1a C 17.5765 -14.5385
20 C1a C 29.4386 -15.5914
BOND 22
1 16 17 1
2 16 18 2
3 17 19 1
4 6 8 1
5 9 10 1
6 12 14 1
7 1 2 1
8 1 3 1
9 1 4 1
10 1 5 1 #Up
11 2 6 2
12 2 7 1
13 3 8 1
14 3 9 1
15 4 10 1
16 6 11 1
17 7 12 2
18 8 13 1
19 11 14 2
20 12 15 1
21 15 16 1
22 9 20 1
|
|---|
